KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Return on Assets: 2009-2025

Historic Return on Assets for Biomarin Pharmaceutical (BMRN) over the last 14 years, with Sep 2025 value amounting to 0.07%.

  • Biomarin Pharmaceutical's Return on Assets rose 2.00% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 2.00%. This contributed to the annual value of 0.06% for FY2024, which is 4.00% up from last year.
  • According to the latest figures from Q3 2025, Biomarin Pharmaceutical's Return on Assets is 0.07%, which was down 23.28% from 0.09% recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Return on Assets ranged from a high of 0.14% in Q2 2021 and a low of -0.01% during Q4 2021.
  • Over the past 3 years, Biomarin Pharmaceutical's median Return on Assets value was 0.04% (recorded in 2024), while the average stood at 0.04%.
  • Within the past 5 years, the most significant YoY rise in Biomarin Pharmaceutical's Return on Assets was 12bps (2021), while the steepest drop was 15bps (2021).
  • Quarterly analysis of 5 years shows Biomarin Pharmaceutical's Return on Assets stood at -0.01% in 2021, then rose by 3bps to 0.02% in 2022, then remained steady at 0.02% in 2023, then increased by 4bps to 0.06% in 2024, then increased by 2bps to 0.07% in 2025.
  • Its Return on Assets stands at 0.07% for Q3 2025, versus 0.09% for Q2 2025 and 0.07% for Q1 2025.